Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
The Journal of Experimental Medicine|November 19, 2003
Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infectionRonald S Veazey, Per Johan Klasse, Thomas J Ketas, et al.Human Vaccines & Immunotherapeutics|July 2, 2013
Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaquesViraj Kulkarni, Margherita Rosati, Jenifer Bear, et al.Journal of Virology|March 28, 2008
Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeysRonald S Veazey, Paula M Acierno, Kimberly J McEvers, et al.Plos Biology|December 6, 2011
Copy number variation of KIR genes influences HIV-1 controlKimberly Pelak, Anna C Need, Jacques Fellay, et al.Journal of Virology|September 8, 2017
HLA-B*14:02-Restricted Env-Specific CD8+ T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV InfectionEllen M Leitman, Christian B Willberg, Ming-Han Tsai, et al.The Journal of Infectious Diseases|January 13, 2010
Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDSJoshua T Herbeck, Geoffrey S Gottlieb, Cheryl A Winkler, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2022
Gut Microbiota, Plasma Metabolomic Profiles, and Carotid Artery Atherosclerosis in HIV InfectionZheng Wang, Brandilyn A Peters, Mykhaylo Usyk, et al.Journal of Virology|July 30, 2003
Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responsesDavid H O'Connor, Bianca R Mothe, Jason T Weinfurter, et al.Science (New York, N.Y.)|January 6, 2018
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cellsVeron Ramsuran, Vivek Naranbhai, Amir Horowitz, et al.The Journal of Clinical Investigation|February 21, 2018
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1Maureen P Martin, Vivek Naranbhai, Patrick R Shea, et al.Pageof 10